Shelton Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,600
Closed -$1.29M 772
2024
Q1
$1.29M Hold
13,600
0.04% 266
2023
Q4
$1.21M Hold
13,600
0.04% 262
2023
Q3
$993K Hold
13,600
0.04% 268
2023
Q2
$1.13M Sell
13,600
-80
-0.6% -$6.69K 0.04% 260
2023
Q1
$1.04M Hold
13,680
0.04% 236
2022
Q4
$1.14M Buy
13,680
+80
+0.6% +$6.48K 0.12% 197
2022
Q3
$1.08M Hold
13,600
0.05% 237
2022
Q2
$1.01M Hold
13,600
0.05% 254
2022
Q1
$1.22M Hold
13,600
0.05% 258
2021
Q4
$1.52M Hold
13,600
0.05% 250
2021
Q3
$1.71M Hold
13,600
0.07% 239
2021
Q2
$1.84M Hold
13,600
0.07% 234
2021
Q1
$1.84M Hold
13,600
0.06% 249
2020
Q4
$1.92M Buy
13,600
+2,800
+26% +$359K 0.09% 210
2020
Q3
$1.2M Sell
10,800
-1,200
-10% -$135K 0.05% 325
2020
Q2
$1.34M Hold
12,000
0.08% 218
2020
Q1
$929K Hold
12,000
0.08% 227
2019
Q4
$1.14M Buy
+12,000
New +$1.04M 0.06% 226

Other funds holding XBI